Description
Pradalex is an innovative third generation fluoroquinolone antibiotic for the treatment of bovine respiratory disease (BRD), only after consideration of other non-fluoroquinolones therapeutic options. Pradofloxacin, the active ingredient in Pradalex, uniquely features two modes of action.
- Concentration dependent antibiotic with a dual mode of action that kills bacteria before they can replicate
- Demonstrated quick elimination from the body, resulting in a shorter withdrawal period.
- Convenient, single dose, low-volume antibiotic with excellent syringeability
- Indicated for the treatment of BRD associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis only after consideration of other non-fluoroquinolones therapeutic options
Reviews
There are no reviews yet.